Beyond DNA Repair: Additional Functions of PARP-1 in Cancer

Abstract

Poly(ADP-ribose) polymerases (PARPs) are DNA-dependent nuclear enzymes that transfer negatively charged ADP-ribose moieties from cellular nicotinamide-adenine-dinucleotide (NAD+) to a variety of protein substrates, altering protein–protein and protein-DNA interactions. The most studied of these enzymes is poly(ADP-ribose) polymerase-1 (PARP-1), which is an excellent therapeutic target in cancer due to its pivotal role in the DNA damage response. Clinical studies have shown susceptibility to PARP inhibitors in DNA repair defective cancers with only mild adverse side effects. Interestingly, additional studies are emerging which demonstrate a role for this therapy in DNA repair proficient tumors through a variety of mechanisms. In this review, we will discuss additional functions of PARP-1 – including regulation of inflammatory mediators, cellular energetics and death pathways, gene transcription, sex hormone- and ERK-mediated signaling, and mitosis – and the role these PARP-1-mediated processes play in oncogenesis, cancer progression, and the development of therapeutic resistance. As PARP-1 can act in both a pro- and anti-tumor manner depending on the context, it is important to consider the global effects of this protein in determining when, and how, to best use PARP inhibitors in anticancer therapy.

Endogeous sulfur dioxide protects against oleic acid-induced acute lung injury in association with inhibition of oxidative stress in rats

“…33 Caspase-3 is a potent, terminal caspase that executes apoptosis. 34,35 Despite advances in the pathogenesis of oxidative stress in ALI, the underlying molecular mechanism remains poorly clarified.…”

The Synergistic Effect of Doxorubicin and Ethanolic Extracts of Caesalpinia sappan L. Wood and Ficus septica Burm. f. Leaves on Viability, Cell Cycle Progression, and Apoptosis Induction of MCF­7 Cells

“…PARP1 can be cleaved by activated caspases. The cleavage of PARP1 will inhibit uncleaved PARP1 activity, thus promote DNA damage response in multiple pathway (Weaver and Yang, 2013). The effect of PARP1 inhibitors in apoptosis induction, providing it as a promising target in cancer therapy (Wang et al, 2012).…”

A New Approach in Cancer Treatment: Poly(ADP-Ribose) Polymerase-1 Inhibitors

“…PARP-1 inhibisyonu, radyasyonun ve kemoterapötik ajanların (metilleyici ajanlar, topoizomeraz I inhibitörleri) sitotoksik etkilerini artırır (4). PARP-1'in kontrol ettiği olaylar Şekil 1'de gösterilmiş-tir (18)(19)(20).…”